Real Health Magazine

2 weeks ago | realhealthmag.com | Liz Highleyman

Women who wear frozen or tight-fitting gloves during taxane-based chemotherapy for breast cancer are less likely to develop painful peripheral neuropathy, according to research published in JAMA Oncology. While both methods were effective, compression is more accessible and may be better tolerated than cold temperature. Cytotoxic chemotherapy is an effective treatment for many types of cancer, but the medications can harm or kill normal cells along with malignant cells, leading to side effects.

2 weeks ago | realhealthmag.com | Liz Highleyman

The Trump administration has rescinded hundreds of National Institutes of Health (NIH) research grants, including many that involve HIV and sexually transmitted infections (STIs). Scientists and advocates have filed a lawsuit to stop the cuts, but prospects for continued funding remain uncertain.

2 weeks ago | realhealthmag.com | Liz Highleyman

Broadly neutralizing antibodies (bnAbs) appeared to help keep HIV under control after stopping antiretroviral therapy and may play a role in long-term remission, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). In the RIO study, three quarters of men who received the bnAbs 3BNC117-LS and 10-1074-LS did not experience viral rebound five months after discontinuing their antiretrovirals, and a third were still in remission at 18 months.

1 month ago | realhealthmag.com | Liz Highleyman

Broadly neutralizing antibodies (bnAbs) may work well with lenacapavir or cabotegravir in long-acting regimens for HIV treatment, according to two presentations this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in San Francisco. One study showed that teropavimab and zinlirvimab, two bnAbs from Gilead Sciences, worked well in combination with twice-yearly lenacapavir (Sunlenca).

1 month ago | realhealthmag.com | Liz Highleyman

The Trump administration may be planning to eliminate or reorganize the Centers for Disease Control and Prevention (CDC) Division of HIV Prevention, possibly as soon as this week, news sources reported late in the day on March 18. Advocates are asking people to call or write to their legislators to urge them to oppose the cuts.